Literature DB >> 11566429

Evidence for altered cerebellar vermis neuronal integrity in schizophrenia.

R F Deicken1, R Feiwell, N Schuff, B Soher.   

Abstract

To determine if there was evidence for altered neuronal integrity in the cerebellar vermis of patients with schizophrenia, the authors measured N-acetyl-aspartate (NAA, a putative neuronal/axonal marker) using in vivo proton magnetic resonance spectroscopic imaging (1H-MRSI) in 20 chronically medicated male patients with schizophrenia and 15 male comparison subjects. Relative contributions of cerebrospinal fluid, gray matter, and white matter to each MRSI voxel were determined using an MRI tissue segmentation technique. The percentage of tissue was used as a co-variate to determine the extent to which tissue composition contributed to NAA differences. Schizophrenic patients showed significantly decreased NAA and creatine in the anterior cerebellar vermis, independent of differences in voxel tissue composition. Cerebellar NAA levels in control subjects were also significantly correlated with the amount of cerebellar gray matter enclosed in the MRSI voxels, but not in the schizophrenic group. There was no association between cerebellar NAA measures and duration of illness or neuroleptic dose in chlorpromazine equivalents. Reduced NAA in the anterior cerebellar vermis of male patients with schizophrenia supports the hypothesis that cerebellar dysfunction contributes to the pathophysiology of schizophrenia. Furthermore, the lack of a significant correlation between NAA and the amount of cerebellar gray matter in MRSI voxels in the schizophrenic group suggests that NAA levels in both cerebellar gray and white matter are similar in schizophrenic patients, and are presumed to be the result of reduced NAA concentration in the cerebellar gray matter.

Entities:  

Mesh:

Year:  2001        PMID: 11566429     DOI: 10.1016/s0925-4927(01)00103-2

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  13 in total

Review 1.  Neurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysis.

Authors:  Nina Vanessa Kraguljac; Meredith Reid; David White; Rebecca Jones; Jan den Hollander; Deborah Lowman; Adrienne Carol Lahti
Journal:  Psychiatry Res       Date:  2012-09-13       Impact factor: 3.222

2.  Disrupted modular architecture of cerebellum in schizophrenia: a graph theoretic analysis.

Authors:  Dae-Jin Kim; Jerillyn S Kent; Amanda R Bolbecker; Olaf Sporns; Hu Cheng; Sharlene D Newman; Aina Puce; Brian F O'Donnell; William P Hetrick
Journal:  Schizophr Bull       Date:  2014-04-29       Impact factor: 9.306

3.  Safety and proof of principle study of cerebellar vermal theta burst stimulation in refractory schizophrenia.

Authors:  Asli Demirtas-Tatlidede; Catarina Freitas; Jennifer R Cromer; Laura Safar; Dost Ongur; William S Stone; Larry J Seidman; Jeremy D Schmahmann; Alvaro Pascual-Leone
Journal:  Schizophr Res       Date:  2010-12       Impact factor: 4.939

4.  Proton magnetic resonance spectroscopy (H-MRS) in chronic schizophrenia. A single-voxel study in three regions involved in a pathogenetic theory.

Authors:  F Granata; G Pandolfo; S Vinci; C Alafaci; N Settineri; R Morabito; A Pitrone; M Longo
Journal:  Neuroradiol J       Date:  2013-07-16

5.  Abnormalities in myelination of the superior cerebellar peduncle in patients with schizophrenia and deficits in movement sequencing.

Authors:  Jitka Hüttlova; Zora Kikinis; Milos Kerkovsky; Sylvain Bouix; Mai-Anh Vu; Nikos Makris; Martha Shenton; Tomas Kasparek
Journal:  Cerebellum       Date:  2014-08       Impact factor: 3.847

6.  Predictive Motor Timing and the Cerebellar Vermis in Schizophrenia: An fMRI Study.

Authors:  Jan Lošák; Jitka Hüttlová; Petra Lipová; Radek Marecek; Martin Bareš; Pavel Filip; Jozef Žubor; Libor Ustohal; Jirí Vanícek; Tomáš Kašpárek
Journal:  Schizophr Bull       Date:  2016-05-17       Impact factor: 9.306

Review 7.  Developing therapeutics for schizophrenia and other psychotic disorders.

Authors:  Gerard Marek; Kalpana Merchant
Journal:  NeuroRx       Date:  2005-10

Review 8.  T2 relaxation effects on apparent N-acetylaspartate concentration in proton magnetic resonance studies of schizophrenia.

Authors:  Bethany K Bracken; Elizabeth D Rouse; Perry F Renshaw; David P Olson
Journal:  Psychiatry Res       Date:  2013-06-12       Impact factor: 3.222

Review 9.  The role of the cerebellum in schizophrenia: from cognition to molecular pathways.

Authors:  Peyman Yeganeh-Doost; Oliver Gruber; Peter Falkai; Andrea Schmitt
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

10.  Gene expression of NMDA receptor subunits in the cerebellum of elderly patients with schizophrenia.

Authors:  Andrea Schmitt; Jiri Koschel; Mathias Zink; Manfred Bauer; Clemens Sommer; Josef Frank; Jens Treutlein; Thomas Schulze; Thomas Schneider-Axmann; Eleni Parlapani; Marcella Rietschel; Peter Falkai; Fritz A Henn
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-05-12       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.